Brexit: what does the draft withdrawal agreement mean for IP?

Robert Watson

Robert Watson
15 Nov 2018

A further step towards a withdrawal agreement between the UK and EU27 occurred on 14 November 2018 with the publication of the fully negotiated version of.

Supreme Court decision signals bad news for patent holders

Nick Sutcliffe

Nick Sutcliffe
14 Nov 2018

The UK Supreme Court issued its decision today on the Warner Lambert vs Generics (UK) Ltd t/a Mylan. The decision concerns Swiss-form patent claims that.

Precision Medicine: the next revolution in healthcare

Frances Salisbury

Frances Salisbury
31 Oct 2018

In recent years, we have witnessed a remarkable healthcare revolution. Thanks to advances in genetic analysis, molecular biology and cell science, we now.

Morphosis: creating and nurturing biotech start-ups in Singapore

Richard Clegg

Richard Clegg
31 Oct 2018

We understand that early-stage biotech companies do not have it easy. It is a long road from pre-clinical research to bringing a product or treatment to.

Development in the War on Superbugs

Matthew Smith

Matthew Smith
29 Oct 2018

The spread of antibiotic-resistant infections is one of the most serious threats in modern medicine. Fuelled by the overuse of existing medicines, the.

JIPA 2018 European Seminar

Matthew Smith

Matthew Smith
08 Oct 2018

The Japanese Intellectual Property Association (JIPA)  has been promoting fair and effective protection of Intellectual Property Rights for over 70 years..

The Pioneering Work of Professor Sir Greg Winter

Seán Walton

Seán Walton
03 Oct 2018

Professor Sir Greg Winter’s pioneering work using phage display for the directed evolution of antibodies has been recognised with a Nobel Prize. Professor.

Navigating the Brexit Landscape: Patents

Robert Watson

Robert Watson
27 Sep 2018

The existing European patent system will be unaffected by the UK leaving the EU, so no action by patent holders is needed.

Changes to Inter Partes Review System for Challenging Granted Patents

Simon Kremer

Simon Kremer
30 Apr 2018

Last week, the U.S. Supreme Court issued two important decisions relating to inter partes review (IPR) proceedings before the Patent Trial and Appeal.  In.